Concerns over “cosy relationship” between the FDA and Moderna
The BMJ reveals how lax rules enable a revolving door culture An investigation published by The BMJ today raises concerns about a revolving door culture between the US Food and Drug Administration (FDA) and Moderna after two regulators who held oversight roles for covid vaccines went to work for the company. During ...